🔴 MDxHealth is trading 16.83% down in pre-market after dilution concerns from a $20 million placement

MDxHealth is trading at $0.67 (-16.83%) in pre-market amid dilution concerns from its registered direct placement.

• The $20 million registered direct placement issued 44,052,862 shares, creating a substantial dilution overhang.
• Selling follows the August 14, 2026 surge of 74.89%, suggesting profit-taking after the earnings-driven spike.
• Q2 revenue reached $27.2 million, beating estimates, but the company reported a wider loss and adjusted EPS of -$0.18 versus a forecast of -$0.17.